SARS-CoV-2 and the COVID-19 disease: a mini review on diagnostic methods
暂无分享,去创建一个
Ester Cerdeira Sabino | E. Sabino | Beatriz Araujo Oliveira | Lea Campos de Oliveira | Thelma Suely Okay | T. Okay | B. A. Oliveira | L. C. Oliveira
[1] N. Tanner,et al. Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP , 2020, medRxiv.
[2] P. Grant,et al. Extraction-free COVID-19 (SARS-CoV-2) diagnosis by RT-PCR to increase capacity for national testing programmes during a pandemic , 2020, bioRxiv.
[3] LAMP-Seq: Population-Scale COVID-19 Diagnostics Using a Compressed Barcode Space , 2020 .
[4] J. Y. Kim. Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR , 2020, Journal of Korean medical science.
[5] R. Lu,et al. Three Novel Real-Time RT-PCR Assays for Detection of COVID-19 Virus , 2020, China CDC weekly.
[6] F. Grosveld,et al. Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection , 2020, Nature Communications.
[7] Tiangang Liu,et al. Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan , 2020, medRxiv.
[8] D. Wang,et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status , 2020, Military Medical Research.
[9] P. Mehta,et al. COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.
[10] Daniel C. Baumgart,et al. Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management , 2020, Clinical Gastroenterology and Hepatology.
[11] Moon-Woo Seong,et al. Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea. , 2020, Annals of laboratory medicine.
[12] J. Rocklöv,et al. COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures , 2020, Journal of travel medicine.
[13] Xiaobo Yu,et al. SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution , 2020, bioRxiv.
[14] Ian Goodfellow,et al. A blueprint for the implementation of a validated approach for the detection of SARS-Cov2 in clinical samples in academic facilities , 2020, bioRxiv.
[15] L. Lopalco,et al. Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art , 2020, Frontiers in Immunology.
[16] R. Soto-Rifo,et al. SARS-CoV-2 detection from nasopharyngeal swab samples without RNA extraction , 2020, bioRxiv.
[17] Scott Tighe,et al. Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction step , 2020, PLoS biology.
[18] Jaber Aslanzadeh,et al. Preventing PCR amplification carryover contamination in a clinical laboratory. , 2004, Annals of clinical and laboratory science.
[19] D. Cummings,et al. A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease , 2020, medRxiv.
[20] Y. Teo,et al. Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review , 2020, Journal of clinical medicine.
[21] Zhenhua Chen,et al. Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay , 2020, Analytical chemistry.
[22] Carol H. Yan,et al. Association of chemosensory dysfunction and COVID‐19 in patients presenting with influenza‐like symptoms , 2020, International forum of allergy & rhinology.
[23] J. Xiang,et al. Evaluation of Enzyme-Linked Immunoassay and Colloidal Gold- Immunochromatographic Assay Kit for Detection of Novel Coronavirus (SARS-Cov-2) Causing an Outbreak of Pneumonia (COVID-19) , 2020, medRxiv.
[24] Yunbao Pan,et al. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients , 2020, Journal of Infection.
[25] SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution , 2020, ACS central science.
[26] Lei Liu,et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections , 2020, medRxiv.
[27] The clinical data from 19 critically ill patients with coronavirus disease 2019: a single-centered, retrospective, observational study , 2020, Journal of Public Health.
[28] Q. Ye,et al. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 , 2020, Journal of Infection.
[29] K. Krogfelt,et al. Evaluation of nine commercial SARS-CoV-2 immunoassays , 2020, medRxiv.
[30] Y. Yazdanpanah,et al. Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients , 2020, Emerging infectious diseases.
[31] Geneviève Pépin,et al. Optimization of SARS-CoV-2 detection by RT-QPCR without RNA extraction , 2020, bioRxiv.
[32] Dae-Gyun Ahn,et al. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19) , 2020, Journal of microbiology and biotechnology.
[33] Shaoqiang Li,et al. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis , 2020, Journal of medical virology.
[34] Eriko,et al. Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR assays , 2020 .
[35] Richard L. Doty,et al. Smell dysfunction: a biomarker for COVID‐19 , 2020, International forum of allergy & rhinology.
[36] A. Tahamtan,et al. Real-time RT-PCR in COVID-19 detection: issues affecting the results , 2020, Expert review of molecular diagnostics.
[37] Heng Zhu,et al. Overview of Protein Microarrays , 2013, Current protocols in protein science.
[38] A. Singh,et al. COVID-19: From bench to bed side , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[39] Victor M Corman,et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[40] P. Horby,et al. A novel coronavirus outbreak of global health concern , 2020, The Lancet.
[41] H. Rothan,et al. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak , 2020, Journal of Autoimmunity.
[42] Z. Tong,et al. Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020 , 2020, Emerging infectious diseases.
[43] Jianfeng Zhang,et al. CT imaging features of 4121 patients with COVID‐19: A meta‐analysis , 2020, Journal of medical virology.
[44] Yuyi Wang,et al. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures , 2020, Journal of medical virology.
[45] T. Qin,et al. Epidemiological and Clinical Characteristics of 26 Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Carriers , 2020, The Journal of Infectious Diseases.
[46] Daeui Park,et al. Comparative analysis of primer-probe sets for the laboratory confirmation of SARS-CoV-2 , 2020, bioRxiv.
[47] A. Ługowska,et al. Laboratory diagnosis of the Niemann-Pick type C disease: an inherited neurodegenerative disorder of cholesterol metabolism , 2019, Metabolic Brain Disease.
[48] Xiaowei Li,et al. Molecular immune pathogenesis and diagnosis of COVID-19 , 2020, Journal of Pharmaceutical Analysis.
[49] Jochen M. Schwenk,et al. Current applications of antibody microarrays , 2018, Clinical Proteomics.
[50] Chaochao Tan,et al. C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early , 2020, Journal of medical virology.
[51] Guillaume Carissimo,et al. Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein , 2020, bioRxiv.
[52] Russell B. Fletcher,et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia , 2020, Science Advances.
[53] Season Wong,et al. The Potential Use of Unprocessed Sample for RT-qPCR Detection of COVID-19 without an RNA Extraction Step , 2020, bioRxiv.
[54] L. Vaira,et al. Anosmia and Ageusia: Common Findings in COVID‐19 Patients , 2020, The Laryngoscope.
[55] Yunbao Pan,et al. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients , 2020, Journal of Infection.
[56] Jaegyun Lim,et al. Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR , 2020, Journal of Korean medical science.
[57] Qi Jin,et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[58] Frank Grosveld,et al. A human monoclonal antibody blocking SARS-CoV-2 infection , 2020, Nature Communications.